We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Anticipates Shortage of Hepatitis B Vaccine
Merck Anticipates Shortage of Hepatitis B Vaccine
January 13, 2009
Merck expects an interruption of U.S. supplies this month for Recombivax HB, the adult formulation of its hepatitis B vaccine, including vials, syringes and dialysis formulations.